THURSDAY OCTOBER 25, 2018 Focus: Celebrating 30 Years of CSAM-SMCA

THURSDAY OCTOBER 25, 2018 Focus: Celebrating 30 Years of CSAM-SMCA

THURSDAY OCTOBER 25, 2018 – Focus: Celebrating 30 years of CSAM-SMCA

8:30 / Welcome: CSAM President, P. Sobey– Columbia
08:45-10:00 / Plenary: The Public Health Impacts of Legalization of Cannabis in the United States: Lessons for Canada - Columbia
Rosalie Pascula, MD (196)
Chair: P Sobey
10:00 – 10:30 / Break – British Columbia FOYER
10:30-12:00 / 30 years of CSAM presentation- Melanie Willows, MD - Columbia
Acknowledgement of Student Bursary recipients
Plenary: SMART Therapy – Tom Horvath
Chair:
12:00-1:30 / Lunch – British Ballroom & Dessert & Coffee with Poster session - Saturna
1:30-3:00 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S1: Advocacy & Translational Research Part I
  • Effecting change: stories of advocacy, policy work and translational research in addiction medicine
Rosalie Pascula
Cheyenne Johnson
Christy Sutherland
Evan Wood
Paxton Bach,
Moderator (186) / S2: Opioid Agonist Therapy with a focus on Methadone
  • Exploring the appropriateness of Benzodiazepines in a Methadone Maintenance Treatment Environment
Donald F. Fay (92)
  • Trajectories of injection drug use among people who use drugs in Vancouver, Canada 1996-2017: Growth mixture modeling based on prospective cohort studies
Huiru Dong (91)
  • Opioid Agonist Treatment (OAT) during residential treatment for opioid use disorder: a cohort study on access and outcomes
Sheryl Spithoff (62)
  • Evaluating the impact of prescribed versus non-prescribed benzodiazepine use in methadone maintenance therapy: results from a population-based retrospective cohort study
Joseph Eibl (51)
  • Impact of methadone induction dose on treatment retention of first-time patients on opioid agonist therapy
Nicole J. Ranger (130)
  • History of opioid agonist therapy use and post-overdose initiation and retention among non-fatal overdose cases in British Columbia, 2015-1016
Alex Crabtree (133)
  • Association between family factors and illicit polysubstance use among methadone maintenance patients with opioid use disorder
Arash Kaur Dhaliwal (136) / S3: Workshop on SMART Recovery
Tom Horvath / S4: CRISM and iOAT
  • Strategies to address Canada’s Opioid Crisis: The CRISM Injectable Opioid Agonist Therapy Initiative
Nadia Fairbairn (161) / S5: History of Research on Gambling & overview of addiction
  • A 20-year Perspective on Gambling Research
Nady el-Guebaly (122)
  • The State of Opioid Agonist Therapy in Canada 20 years after Federal Oversight
Patrick Oghene& Eleanor Vandermeer(109)
  • How is Opioid Addiction Treated in Other Countries?
Al Jones(111)
3:00-3:30 / Break ??? / Break – OAKES FOYER
3:30-5:00 / Columbia / Waddington / Vancouver / Gabriola / Galiano
Poster Award for Student
S6: Advocacy & Translational Research Part 2
  • Effecting change: stories of advocacy, policy work and translational research in addiction medicine
Paxton Bach (186) / S7: Youth & Emerging Adults
  • Factors associated with excessive student driving on Canadian campuses
Shawna Meister (58)
  • The winding journey to excellence: Sharing the successes and challenges encountered in the development and opening of an inpatient adolescent concurrent disorders program
Michelle Danda (142)
  • Temporal trends in the association between cannabis use and mental health in a nationally representative sample of Canadian young and middle-aged adults
Jillian Halladay (102)
  • Perceived devaluation among a cohort of street-involved youth in Vancouver, Canada
Mohammad Karamouzian (88)
  • The prevalence of substance use among Pediatric Psychiatric Inpatients: A systematic review
SinthujaSuntharalingham (127)
  • Concurrent treatment for concurrent disorders: delivering integrated treatment for youth with moderate to severe mental health and substance use disorders
Andrew Lumb (158)
  • Medicinal Cannabis use among university students: Findings from the U Calgary campus experience with Cannabis Survey
Jacqueline Smith (97) / S8: Research Projects of the BCCSU
  • Implementation during a Crisis: An Overview of the BC Centre on Substance Use: Provincial Impacts and Work to Date
Cheyenne Johnson (115) / S9: Acute Care & Addictions
  • A brief description of the evolution of North America’s largest inpatient addiction medicine consultation service
Vivian Braithwaite (107)
  • Implementation supervised consumption services in acute care: Insights for supporting patients who use drugs
Kathryn Dong (120)
  • Patient perspectives on injection drug use and sterile syringe distribution in acute care
Elaine Hyshka (124)
  • Harm reduction interventions among hospital inpatients who inject drugs in Halifax, Nova Scotia
Thomas Brothers (123)
  • Predictors of being offered a Take-Home Naloxone kit in a busy, urban emergency department
Daniel O’Brien (135)
  • A descriptive analysis of a substance use consultation service in an acute psychiatric care setting inn Vancouver, Canada
Colin McWilliams (85)
  • Who leaves inpatient medical withdrawal services against medical advice?
Sara Ling(94) / S10: Pain management in Addictions & Mental Health Problems
  • Treating pain in people with addiction and mental health challenges
LaunetteRieb (113)
5:00-7:00 / Welcome Reception – The Roof

FRIDAY OCTOBER 26, 2018 – Focus: The Nursing profession and Care

7:00-8:00 / Mutual Help Meeting – British YOGA session –
7:30 / Committee Meetings
8:30-10:00 / Welcome– Conference Committee Co-Chairs: Paul Sobey & Jennifer Brasch – Columbia
The “S” Team: Nursing and Interprofessional Teams during an Overdose Epidemic - Columbia
Bernice Pauly 203
Chair: P Sobey
10:00-10:30 / Break – British Columbia FOYER
10:30-12:00 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S11: Enhancing nursing practice/competency development
  • Exploring Canadian Nursing-led models of substance use care: A review of the gaps and innovative practices
Danielle Cousineau (132)
  • Development of Core Competencies for the BCCSU Addiction Nurse Practitioner Fellowship
Zak Matieschyn (129)
  • Working to full scope: Nursing Competencies for practice in managed alcohol programs and alcohol harm reduction
Meaghan Brown (110)
  • Promoting Excellence: Nursing Competency Development for an Inpatient Medical Withdrawal Management Center
Nicole Cowan (185)
  • The evaluation of alcohol withdrawal using the CIWA-Ar, a validated and standardized, scale: the contribution of clinical nursing judgement
(L’évaluation du sevraged’alcool à l’aide du CIWA-Ar, uneéchellevalidée et normalisée: la contribution du jugement Clinique infirmier)
Emilie Lizotte-Chin (75) / S12: Emerging Nursing practice
  • Addiction Assessment Nurse in St. Paul’s Hospital Emergency Department
Emma GarrodJennifer Funo (169)
  • Implementing Rapid, Low-barrier access to Opiate Agonist Treatment using a shared care model – downtown Eastside connections
Leila Gold Jacey Larochelle (119)
  • Lessons learned: Saskatchewan Regulatory Framework Process to enable registered Nurse and Nurse Practitioner harm Reduction practices
Leland Sommer & Donna Cooke (167) / S13: New Addictions Credentialing Processes: Royal College and CCFP
  • New Addictions Credentialing Processes: Royal College and CCFP
Nady el-Guebaly (201) / S14: Workshop on ACT
  • Acceptance and Commitment Therapy (ACT) Workshop
Larisa Eibsich (118) / S15: Nursing stream: Innovation n care delivery
  • Preliminary Research Findings: Exploring the experience of inpatients with severe alcohol use disorder on a managed alcohol program (MAP) at St. Paul’s Hospital
Eric Eligh (134)
  • Working collaboratively to increase HCV testing and treatment amongst people who inject drugs
Sandi Mitchell (184)
  • Clinical & Community Partnerships in the Opioid Crisis: a rural response
Kate Hodgson (192)
  • Implementation of Injectable Opioid Agonist Therapy in a primary care integrated care health centre
Terry Hobot & Marie Sproule (172)
12:00-1:30 / Lunch – British ballroom
Networking area for residents and med students
1:30-3:30 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S16: PTSD & Addictions
  • Post-Traumatic stress disorder as a predictor of residential treatment dropout: Findings from a large cohort of patients from the Homewood Health Addiction Medicine Services
Sabina Kaur Syan (145)
  • Evidence-based practices for treating concurrent trauma and addiction: lessons learned and early treatment outcomes from incorporating group
HollamSutander (147)
  • A brief introduction into the science behind the co-occurrence of post-traumatic stress disorder and substance use disorders: an overview of leading hypotheses that may explain PTSD-SUD comorbidity
Vivian Sarabia (153)
  • Treating co-occurring post-traumatic stress disorder and substance use disorders: A look into the science, treatment outcomes and promising practices
Jean Costello (157)
  • Use of a top down cognitive remediation strategy in patients with affective disorders: Preliminary results and implications for use in addictions
Margaret McKinnon (144) / S17: Women’s Issues
  • Maternal smoking during pregnancy: a review of the effects of maternal tobacco use on fetal brain development
Molonga Simon (49)
  • Cannabis in pregnancy and breastfeeding
Erin Lurie (117)
  • Opioids: What’s new in pregnancy and newborn care
Suzanne Turner (140)
  • Caring for women in Opioid Agonist Treatment Programs
Suzanne Turner (141)
  • Prenatal care outcomes for women with substance use disorders
Robin Lennox (170) / S18: Workshop: Ingredients for system change: A workshop on advocacy at the front lines (Nursing Symposium)
  • Ingredients for system change: A workshop on advocacy at the front lines
Samantha Robinson (206)
  • Reducing wait times for opioid treatment: Going from the longest in the province to the shortest
Laura ChapmanChera Clements(116)
  • There is an opioid overdose crisis and we need all hands on deck!
Cristina Zaganelli (146) / S19: Crosstown Clinic
  • From cost-effectiveness to patient-centered care: advancing the evidence and policy for injectable opioid agonist treatment in Canada
Eugenia Oviedo-Joekes (69)
  • Comparison of treatment retention among patients receiving open-label injectable hydromorphone from the period when they received double-blinded treatment in the SALOME trial
Eugenia Oviedo-Joekes (70)
  • Patient-centered care in injectable Opioid Agonist Treatment for opioid use disorder
Kirsten Marchand (71)
  • Cost-effectiveness of hydromorphone for severe opioid disorder: findings from the SALONME randomized clinical trial
Nick Bansback (72)
  • Nursing therapeutic relationship and its role on patients’ daily attendance and street opioid use among patients receiving injectable opioid agonist treatment at Crosstown Clinic
Scott Harrison (76) / S20: Education in Addictions – Fellowship programs (CSAM-SMCA Education Committee)
  • Who learns the most about addictions in hospitals? A mixed methods study
Jan Klimas (56)
  • Addiction medicine mentorship: Capacity building through relationship building
Kate Hardy (106)
  • The ABC’s of Addiction Fellowship Programs in Canada
Melanie Willows
AneesBahji
Annabel Mead
Nikki Bozinoff
Ron Lim
Lydia Vezina
Ronald Fraser
Kim Corace (128)
3:30-4:00 / Break – British Columbia Foyer
4:00-5:00 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S21: Tim Stockwell / S22: Cognitive Strategies to Support Recovery
  • Acceptance and commitment Therapy in Addiction Medicine
Vincent Lam (98)
  • Comfort Plan: an innovative tool to manage distress and crisis in patients with substance use and mental health problems
Louise Overington(101)
  • This could be my last change: Therapeutic optimism in a substance use disorder randomized controlled trial
Kaitlyn Jaffe (164) / S23: Workshop: An Atypical Opioid Overdose: Emerging Trends and Complexities (Nursing)
  • Atypical Opioid Overdose: Emerging trends and complexities
Ellery Cleveland (205) / S24: Other Addictions
  • Chronic cocaine alters impulsive choice differentially depending upon pre-existing basal impulsive choice levels: implications for the etiology of cocaine addiction
Eliott Gardner (60)
  • Treating GHB withdrawal with high-dose Baclofen: a case report
Mark McLean (138)
  • Connection of PWUD at supervised consumption services to Pathways of Care – Are we meeting the needs of crystal methamphetamine users?
Arash Kaur Dhaliwal (139) / S25: Panel: Publishing Guidelines for Authors: an Introduction; Sponsored by the Canadian Journal of Addictions
  • CJA Publishing Guidelines for Authors: An Introduction
Nady el-Guebaly (202)
5:30-8:30 / Optional Social event – Bill Reid Gallery of Northwest Coast Art

SATURDAY OCTOBER 27, 2018 – Focus: Issues of Indigenous Peoples and Addictions

7:30 / CSAM-SMCA Annual General Meeting - British ballroom
7:45 / INSITE Tour
9:00-10:30 / Welcome– Conference Committee Co-Chairs: Paul Sobey & Jennifer Brasch – Columbia
People’s Choice Award Best Poster
Plenary: - Columbia
Harold Johnston, MD
Chair:
10:30-11:00 / Break – British Columbia FOYER
11:30 / CROSSTOWN Tour
11:00-12:15 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S26: Meeting First Nations Communities Where they are at: Challenges and Innovations in addressing Substance Abuse
NelWieman / S27: Innovative Addiction Care in Montreal
  • How can we lower the threshold for opioid agonist treatment? The example of the Relais Clinic in Montreal
Marie-Eve Goyer (148)
  • Wet shelters ad wet services: effects, issues and challenges
Jorge Flores-Aranda (151)
  • A typology of opioid utilization to develop tailored clinical intervention: preliminary results from a Montreal study
Michel Perreault (165)
  • Beyond safe injection: the evolution of the nursing practice in Montreal’s SIS
Elaine Polflit (180) / S28: Workshop: An Indigenous Residential Treatment Program
  • A workshop on the impact of a response to the Opioid Crisis on Indigenous Communities in Northern Canada by an Indigenous Residential Treatment Centre, Benbowopka
Teresa Naseba Marsh (114) / S29: Workshop: Implantable Buprenorphine
  • Using implantable Buprenorphine for the treatment of opioid Use Disorder
Michael Frost (63) / S30: Front-line, team-based care
  • Martin Street Outreach Centre: Team based care wrap around care
Kyle Stevens (126)
  • Opioid overdose: Increasing 911 calls through Good Samaritan Law to save lives
Kim Lan St-Pierre (81)
  • The British Columbia Centre on Substance Use Addiction Social Work Fellowship: A novel program in Canada Cody Callon (125)
  • The BOOST Collaborative teams at the frontlines of the opioid crisis in Vancouver are driving system change to improve care
Cole Stanley(154)
12:15-1:30 / Lunch – British Ballroom
1:30-3:00 / Columbia / Waddington / Vancouver
S33: Buprenorphine
  • Strategies and associated outcomes for transfer from methadone to buprenorphine for medication-assisted treatment for opioid use disorders: a systematic review
Mandy Manak (166)
  • Transitioning from Methadone to Suboxone using SROM: a Case series
Abhishek Jariwala (168)
  • Buprenorphine in the emergency department (BED): a randomized clinical control trial of clonidine versus buprenorphine for the treatment of opioid withdrawal
Anita Srivastava (188)
  • Efficacy, safety and injection site tolerability of RBP-6000 in the treatment of opioid use disorder: results from 2 Phase III Trials
Gail Kaempf (162)
  • Higher abstinence rates with greater Buprenorphine exposure among patients who inject opioids
Jan Kozicky (163)
  • A patient centered approach to initiation of Buprenorphine/Naloxone for treatment of opioid use disorder: a case report
Kate Colizza(89)
  • Utilizing micro-dosing of Buprenorphine/Naloxone to treat opioid use disorder in an inpatient setting: a case report
MaulikBaxi (181) / Gabriola / Galiano
S31: Seniors and Addictions
  • New substance use disorder treatment guidelines in older adults from the Canadian Coalition for Seniors Mental health
LaunetteRieb
Amy Porath
Indira Fernando
(112) / S32: Addiction Issues in Indigenous Communities
  • Sociodemographic profiles and clinical outcomes for clients on methadone treatment in Prince Albert, Saskatchewan: Implications for practice
Geoffrey M. Maina (47)
  • Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada
Andreas Pilarinos (64))
  • A unique and holistic approach to understanding and addressing pain in indigenous women who have experienced violence
Angela Heino (74)
  • Long term treatment outcomes in a First Nations High School population with opioid use disorder
Anita Srivastava (187) / S34: Culture as Healing and Anti-Oppressive Practices (2 workshops 45 minutes each)
  • Beyond SDoH: Anti-Oppressive Practice in Addictions Care
Jacqueline Vincent (83)
  • Culture as healing in a community based program for opioid use disorder
Jennifer Wyman (137) / S35: Addiction Treatment in rural settings
  • Evaluating the effectiveness of concurrent Opioid Agonist treatment and psychiatry across Northern, Rural and Urban regions of Ontario, Canada
Kristen Morin (61)
  • Rural Outreach for Addiction Management
Sumantra Monty Ghosh (195)
3:00-3:30 / Break – British Columbia FOYER
3:30-4:30 / Columbia / Waddington / Vancouver / Gabriola / Galiano
S36: Workshop: First Nations community-based Treatment program
  • First Nations Community Based Treatment program
Claudette Chase (86) / S37: Workshop: Treatment of Nicotine Use Disorder
  • Treating Tobacco Use Disorder: an update on the latest research and tends
Milan Khara (159)Peter Selby / S38: Top 10 papers in addictions 2017-18 and Practicing addiction medicine in a fee-for-service model
  • Review of the top 10 highest impact publications in Addiction Medicine in 2017-2018
Monique Moller (121)
  • Family physician care for substance use disorders within the fee-for-service model: Benefits, challenges and recommendations
Jill Fairbanks & Sharon Cirone(67) / S39: Alcohol Use Disorder Treatment
  • Newer detoxification protocols for alcohol or opioid dependence in medically compromised, hospitalized patients
Peter Chan (55)
  • Treatment of alcohol use disorder among South Asians in Surrey BC: a qualitative study
Natasha Puri (53)
  • Initiation of Pharmacological Treatment for Alcohol Use Disorder (AUD) in the Emergency Department (ED): A Systematic Review
Jonathan Gravel(178) / S40: Communicable Diseases
  • A “TEEMAPP” approach to co-morbid Hepatitis C care & substance use disorder
Chris Cavacuiti(52)
  • Sharing of equipment for the preparation of a controlled-release oral opioid for injection is associated with HIV transmission: A mixed methods study
Laura Ball (80)
  • Impact of homelessness on active drug use and successful HCV therapy: a mixed methods analysis
AstouThiam (177)
3:30-4:00 / Conference Closing P Sobey & J Brasch – Columbia

SUNDAY OCTOBER 28, 2018

8:30-16:30 / FUNDAMENTALS OF ADDICTION MEDICINE - room: Vancouver / INHSU – room: Waddington
8:30 / Welcome
8:35-9:25 / Models of Disease/Psychologicval Aspects of Addiction Medicine
Dr. LaunetteRieb
9:30-10:20 / Alcohol Use Disorders & SBIRT
Dr. Ron Fraser
10:20-10:35 / BREAK
10:35-11:25 / Opioid Use Disorders
Dr. Alex Chan
11:30-12:00 / Office-based Practice tips
Dr. John Koehn
12:00-12:15 / Role Play / Q&A
12:15 – 1:15 / LUNCH
1:15-1:30 / Stimulant Use Disorders
Dr. John Koehn
1:35-2:10 / Benzodiazepine Disorders
Dr. Larina Reyes-Smith
2:15-3:00 / Concurrent Disorders
Dr. Pouya
3:00-3:15 / BREAK
3:15-4:00 / Cannabis Use Disorders
Dr. Nick Matthew
4:00-4:30 / Round table
4:30 / Wrap up